Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation

Ordemann, R.; Stöhlmacher, J.; Beuthien-Baumann, Bettina; Platzek, Ivan; Hoff, Jörg van den; Kroschinsky, F.; Middeke, J. M.; Platzbecker, U.; Zietz, C.; Bornhäuser, M.; Ehninger, G.

doi:10.1007/s00277-012-1524-0

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation

Ordemann, R.; Stöhlmacher, J.; Beuthien-Baumann, B.; Platzek, I.; van den Hoff, J.; Kroschinsky, F.; Middeke, J. M.; Platzbecker, U.; Zietz, C.; Bornhäuser, M.; Ehninger, G.

Abstract

Letter to the editor - kein Abstract verfügbar

Involved research facilities

PET-Center

Annals of Hematology 92(2013), 125-127
DOI: 10.1007/s00277-012-1524-0
Cited 24 times in Scopus

Permalink: https://www.hzdr.de/publications/Publ-17499